✦ LIBER ✦

285 Capecitabine and mitomycin C (MMC) is an active well-tolerated regimen as first line treatment for metastatic colorectal cancer (MCRC)

✍ Scribed by S. Rao; D. Cunningham; M.E. Hill; T.J. Price; P. Shellito; N. Tebbutt; A.R. Norman; J. Oates

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6001 International randomised phase III

✍ Tebbutt, N.; Gebski, V.; Wilson, K.; Cummins, M.; Robinson, B.; Broad, A.; Cunni 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

276 Promising activity with capecitabine

✍ J.L.B. Dickson; S. Rao; M.E. Hill; T.J. Price; A.R. Norman; J. Oates; D. Cunning 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

5081 Triple combination of 3-weekly tras

✍ R. Palumbo; A. Bernardo; M.R. Strada; G. Poggi; C. Teragni; A. Amatu; M. Frascar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB